Search

Your search keyword '"OPMD"' showing total 285 results

Search Constraints

Start Over You searched for: Descriptor "OPMD" Remove constraint Descriptor: "OPMD"
285 results on '"OPMD"'

Search Results

1. Is Binary Grading Better Than WHO System for Grading Epithelial Dysplasia? A Systematic Review and Meta‐Analysis.

2. Biological biomarkers of oral cancer.

3. Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy

4. Areca nut-induced metabolic reprogramming and M2 differentiation promote OPMD malignant transformation

5. Diseases with oral malignant potential: Need for change to inform research, policy, and practice.

6. Areca nut-induced metabolic reprogramming and M2 differentiation promote OPMD malignant transformation.

7. Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview.

9. Specific Oral Microbial Differences in Proteobacteria and Bacteroidetes Are Associated with Distinct Sites When Moving from Healthy Mucosa to Oral Dysplasia—A Microbiome and Gene Profiling Study and Focused Review

10. Analysis of single nucleotide polymorphism of p16 gene in cytological samples of patients with oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC)

11. Prevalence and risk factors of oral potentially malignant disorders in Indonesia: a cross-sectional study undertaken in 5 provinces

13. State of the Art in the Diagnosis and Assessment of Oral Malignant and Potentially Malignant Disorders: Present Insights and Future Outlook—An Overview.

14. General dentists' knowledge, perceptions, and practices regarding oral potentially malignant disorders and oral cancer in Indonesia.

15. Salivary metabolomics in oral potentially malignant disorders and oral cancer patients—a systematic review with meta-analysis.

16. Wound healing after therapy of oral potentially malignant disorders with a 445-nm semiconductor laser: a randomized clinical trial.

17. Use of fluorescence imaging and spectrometry in detection of oral squamous cell carcinoma and oral potentially malignant disorders

18. General dentists' knowledge, perceptions, and practices regarding oral potentially malignant disorders and oral cancer in Indonesia

19. Distribution of Epstein-Barr virus in the oral cavity of Thais with various oral mucosal conditions

20. Introducing the Dysphagiameter: a novel patient-reported outcome measure for evaluating dysphagia in oculopharyngeal muscular dystrophy - from conceptual framework to initial development.

21. Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case–Control Study.

22. The National Israeli Registry for Oculo-Pharyngeal Muscular Dystrophy (IsrO-PMD): rationale and design.

23. The Magic Triangle in Oral Potentially Malignant Disorders: Vitamin D, Vitamin D Receptor, and Malignancy.

24. Oral Leukoplakia. A Five-Year Follow-Up Study.

25. Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.

26. Assessment of Ploidy Status in Oral Potentially Malignant Disorders -- A Systematic Review.

27. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma

28. Assessment of ploidy status in oral potentially malignant disorders – A systematic review

30. Oral cavity carcinoma in patients with and without a history of lichen planus: A comparative analysis.

31. The Level of Knowledge of Dental Profession Students of Universitas Airlangga on Leukoplakia as an Oral Potentially Malignant Disorder: An Observational Analytic Cross-Sectional Study.

32. State of the Art in the Diagnosis and Assessment of Oral Malignant and Potentially Malignant Disorders: Present Insights and Future Outlook—An Overview

33. The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response

34. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.

35. Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma.

36. A review of surgical management of progressive myogenic ptosis.

37. Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder

38. Evaluation of the Prevalence and Potential Impact of HPV Vaccines in Patients with and Without Oral Diseases: A Ten-Year Retrospective Study.

40. Association of micronuclear frequency with dysplasia and cytogenetic changes (p53 mutation and p16 expression) in oral potentially malignant disorders

41. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.

42. BCL2 expression in OPMD and OSCC - An immunohistochemical study on 70 samples.

43. Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy.

44. Assessment of the oral cancer control activities through care seeking behavior of hospital attendees and their level of awareness

45. Specific Oral Microbial Differences in Proteobacteria and Bacteroidetes Are Associated with Distinct Sites When Moving from Healthy Mucosa to Oral Dysplasia—A Microbiome and Gene Profiling Study and Focused Review

46. Precise Identification of Oral Cancer Lesions Using Artificial Intelligence.

47. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.

48. Unified M-estimation of matrix exponential spatial dynamic panel specification.

49. BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy

50. Oral potentially malignant disorders: advice on management in primary care.

Catalog

Books, media, physical & digital resources